Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and Alphatec Holdings (ATEC)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xenon (XENE – Research Report) and Alphatec Holdings (ATEC – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Xenon (XENE)
In a report released today, Tessa Romero from J.P. Morgan reiterated a Buy rating on Xenon, with a price target of $62.00. The company’s shares closed last Tuesday at $44.79, close to its 52-week high of $46.00.
According to TipRanks.com, Romero is a 4-star analyst with an average return of
Currently, the analyst consensus on Xenon is a Strong Buy with an average price target of $55.63, a 28.3% upside from current levels. In a report issued on February 23, Wolfe Research also initiated coverage with a Buy rating on the stock with a $60.00 price target.
See the top stocks recommended by analysts >>
Alphatec Holdings (ATEC)
Morgan Stanley analyst Patrick Wood maintained a Hold rating on Alphatec Holdings today and set a price target of $23.00. The company’s shares closed last Tuesday at $13.93, close to its 52-week high of $14.54.
According to TipRanks.com, Wood is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alphatec Holdings with a $24.67 average price target, implying an 87.2% upside from current levels. In a report released today, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $14.00 price target.
